SCHEMBL18798927

SCHEMBL18798927

CSCN1C2C=C(C(C)C)CC1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19432816 0.82 SIGMAR1 (0.35) —
SCHEMBL25492728 0.74 SLC6A2 (0.45) —
SCHEMBL19174820 0.74 SLC6A2 (0.45) —
SCHEMBL17427854 0.71 SLC6A2 (0.30) —
SCHEMBL16000535 0.71 SLC6A2 (0.30) —
SCHEMBL18798943 0.71 SLC6A2 (0.30) —
SCHEMBL1335594 0.61 SLC6A4 (0.44) —
SCHEMBL13218287 0.58 SIGMAR1 (0.33) —
SCHEMBL24364555 0.54 SLC6A2 (0.46) —
SCHEMBL18798712 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9637458-B2 Pyrimidine carboxamides as sodium channel blockers PURDUE PHARMA L.P. 2017-05-02 — — US disclosed
Send feedback